| WB | 1/1000 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 咨询技术 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | Transcription elongation regulator 1, TATA box-binding protein-associated factor 2S, Transcription factor CA150, TCERG1, CA150, TAF2S |
| Entrez GeneID | 10915 |
| WB Predicted band size | 123.9kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | This TCERG1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 991-1020 amino acids from the C-terminal region of human TCERG1. |
| Formulation | Purified antibody in PBS with 0.05% sodium azide. |
+ +
以下是关于TCERG1抗体的参考文献示例：
1. **文献名称**：*TCERG1 regulates alternative splicing by interacting with spliceosomal components*
**作者**：Smith A, et al.
**摘要**：本研究通过免疫共沉淀(Co-IP)和Western blot技术，利用TCERG1特异性抗体，揭示了TCERG1与剪接因子(如SF3B1)的相互作用，表明其在RNA剪接调控中的关键作用。
2. **文献名称**：*Dysregulation of TCERG1 in Huntington’s disease models*
**作者**：Johnson R, et al.
**摘要**：通过免疫组化和小鼠脑组织Western blot分析，作者使用TCERG1抗体发现其表达水平在亨廷顿病模型中显著降低，提示其可能与神经退行性病变相关。
3. **文献名称**：*TCERG1 modulates transcriptional elongation in leukemia cells*
**作者**：Lee H, et al.
**摘要**：结合ChIP-seq和免疫荧光技术(使用TCERG1抗体)，研究发现TCERG1通过结合RNA聚合酶Ⅱ调控转录延伸，影响白血病细胞的增殖与分化。
4. **文献名称**：*Development and validation of a monoclonal antibody against human TCERG1*
**作者**：Chen L, et al.
**摘要**：本文报道了一种新型TCERG1单克隆抗体的制备与验证，通过ELISA、免疫印迹和免疫荧光实验证实其高特异性和适用性，为后续功能研究提供工具。
(注：以上文献为示例，非真实存在，仅展示格式与内容框架。)
×
